₹0.00

Listing Status:
Online platform for at-home diagnostic tests and health checkups. It offers full body checkups and blood tests with home sample...
Total Rounds: 11 Healthians
| S.No. | Date | Round Name | Amount | TTM Revenue | Investors & Facilitators |
|---|---|---|---|---|---|
| 1. | Jan 3, 2022 | Series C | ₹407 Cr | ₹153 Cr | Inst: WestBridge Capital, Trifecta Capital, Konark Trust, MMPL Trust |
| 2. | 2022 | Grant (prize money) | - | ₹144 Cr | Inst: ACT Grants |
| 3. | Dec 16, 2021 | Series B | ₹61 Cr | ₹144 Cr | Inst: Beenext, Mistletoe, Kotak Mahindra Bank, Ysinvestment, DG Ventures |
| 4. | Aug 21, 2019 | Series B | ₹85 Cr | ₹37 Cr | Inst: DG Daiwa Ventures, Trifecta Capital, Tokio Marine, DGLabs, Beenos, M&S Partners, Beenext, DG Ventures, Kotak Investment Advisors, Tokio Marine, DG Incubation, Mistletoe, SIN Capital, Tokio Marine & Nichido Fire Insurance Angel: Jean, Walter, Mamoru, Taniya |
| 5. | Dec 14, 2018 | Series A | ₹1.3 Cr | ₹30 Cr | Inst: Trifecta Capital, Brand Capital |
| 6. | Feb 6, 2018 | Conventional Debt | ₹5.1 Cr | ₹18 Cr | Inst: DGLabs Angel: Walter T, Jean Pierrie, Mamoru |
| 7. | May 4, 2017 | Series A | ₹16 Cr | ₹9.3 Cr | Inst: Beenext, Beenos, YouWeCan Ventures, M&S Capital Partners, MAFFIN, Ignis Inc, DG Ventures, Maffin Angel: Yuvraj, Taniya, Jean, Walter T, Chigusa, Deepak |
| 8. | Oct 17, 2016 | Series A | ₹11 Cr | ₹4.9 Cr | Inst: Beenext, Beenos, DG Ventures Angel: Oleg |
| 9. | Nov 10, 2015 | Seed | ₹6.8 Cr | ₹79.0 Lakh | Inst: Beenext, M&S Capital Partners, Dinco Overseas, DG Ventures |
| 10. | Aug 21, 2015 | Seed | ₹85.7 Lakh | ₹49.5 Lakh | Inst: YouWeCan Ventures, Mconverge Ventures, Vnu Technologies Angel: Aprameya, Subramanya |
| 11. | Sep 11, 2014 | Angel | ₹20.0 Lakh | ₹22,353 | Angel: Sharda, Chandan, Medha, Rajneesh, Anil, Sunil, Suhail, Pradeep |
| Detailed Income Statement | FY 25-26 (in Cr) |
|---|---|
| 361.5 | |
| 364.1 | |
| Total profit before exceptional items, extraordinary items and tax | (2.7) |
| Exceptional items before tax | 8.5 |
| Total profit before tax | 5.8 |
| Total tax expense | 0 |
| Total profit (loss) for period from continuing operations | 5.8 |
| Profit (loss) from discontinuing operations before tax | (0.4) |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | (0.4) |
| Total profit (loss) for period | 5.4 |
| Basic earning per equity share | 0.0 |
| Detailed Balance Sheet | FY 25-26 (in Cr) |
|---|---|
| 163.4 | |
| 163.4 |
| Detailed Cash Flow Statement | FY 25-26 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | (10.8) |
| Net cash from / (used in) investing activities | (22.1) |
| Net cash from / (used) in financing activities | 8.4 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (24.4) |
| Net increase / (decrease) in cash and cash equivalents | (24.4) |
| Cash and cash equivalents at the beginning of the year | 29.1 |
| Cash and cash equivalents at the end of the year | 4.7 |
| Detailed Income Statement | FY 24-25 (in Cr) |
|---|---|
| 270.5 | |
| 275.2 | |
| Total profit before exceptional items, extraordinary items and tax | (4.8) |
| Exceptional items before tax | 0 |
| Total profit before tax | (4.8) |
| Total tax expense | 0 |
| Total profit (loss) for period from continuing operations | (4.8) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | (4.8) |
| Basic earning per equity share | (0.0) |
| Detailed Balance Sheet | FY 24-25 (in Cr) |
|---|---|
| 224.2 | |
| 224.2 |
| Detailed Cash Flow Statement | FY 24-25 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | 9.3 |
| Net cash from / (used in) investing activities | 29.1 |
| Net cash from / (used) in financing activities | (19.1) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 19.4 |
| Net increase / (decrease) in cash and cash equivalents | 19.4 |
| Cash and cash equivalents at the beginning of the year | 9.7 |
| Cash and cash equivalents at the end of the year | 29.1 |
| Detailed Income Statement | FY 23-24 (in Cr) |
|---|---|
| 252.7 | |
| 297.7 | |
| Total profit before exceptional items, extraordinary items and tax | (45.0) |
| Total profit before tax | (45.0) |
| Total tax expense | 0 |
| Total profit (loss) for period from continuing operations | (45.0) |
| Total profit (loss) for period | (45.0) |
| Detailed Balance Sheet | FY 23-24 (in Cr) |
|---|---|
| 220.6 | |
| 220.6 |
| Detailed Cash Flow Statement | FY 23-24 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | (41.0) |
| Net cash from / (used in) investing activities | 77.3 |
| Net cash from / (used) in financing activities | (42.0) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (5.7) |
| Effect of exchange rate changes on cash and cash equivalents | 0.0 |
| Net increase / (decrease) in cash and cash equivalents | (5.7) |
| Cash and cash equivalents at the beginning of the year | 15.4 |
| Cash and cash equivalents at the end of the year | 9.7 |
| Detailed Income Statement | FY 22-23 (in Cr) |
|---|---|
| 235.8 | |
| 365.1 | |
| Total profit before exceptional items, extraordinary items and tax | (129.3) |
| Total profit before tax | (129.3) |
| 0 | |
| Total profit (loss) for period from continuing operations | (129.3) |
| Total profit (loss) for period | (129.3) |
| Detailed Balance Sheet | FY 22-23 (in Cr) |
|---|---|
| 301.9 | |
| 301.9 |
| Detailed Cash Flow Statement | FY 22-23 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | (143.7) |
| Net cash from / (used in) investing activities | 86.8 |
| Net cash from / (used) in financing activities | (34.3) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (91.3) |
| Net increase / (decrease) in cash and cash equivalents | (91.3) |
| Cash and cash equivalents at the beginning of the year | 106.6 |
| Cash and cash equivalents at the end of the year | 15.4 |
| Detailed Income Statement | FY 21-22 (in Cr) |
|---|---|
| 169.3 | |
| 745.0 | |
| Total profit before exceptional items, extraordinary items and tax | (575.8) |
| Total profit before tax | (575.8) |
| Total tax expense | 0 |
| Total profit (loss) for period from continuing operations | (575.8) |
| Total profit (loss) for period | (575.8) |
| Detailed Balance Sheet | FY 21-22 (in Cr) |
|---|---|
| 470.2 | |
| 470.2 |
| Detailed Cash Flow Statement | FY 21-22 (in Cr) |
|---|---|
| Net cash from / (used in) operating activities | (114.6) |
| Net cash from / (used in) investing activities | (186.1) |
| Net cash from / (used) in financing activities | 395.9 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 95.3 |
| Net increase / (decrease) in cash and cash equivalents | 95.3 |
| Cash and cash equivalents at the beginning of the year | 11.4 |
| Cash and cash equivalents at the end of the year | 106.6 |
| Detailed Income Statement | FY 20-21 (in Cr) |
|---|---|
| 68.7 | |
| 113.2 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (44.5) |
| Total profit before extraordinary items and tax | (44.5) |
| Total profit before tax | (44.5) |
| 0 | |
| Total profit (loss) for period from continuing operations | (44.5) |
| Total profit (loss) for period before minority interest | (44.5) |
| Total profit (loss) for period | (44.5) |
| Basic earning per equity share | 0 |
| Diluted earnings per equity share | 0 |
| Detailed Balance Sheet | FY 20-21 (in Cr) |
|---|---|
| 81.9 | |
| 81.9 |
| Detailed Cash Flow Statement | FY 20-21 (in Cr) |
|---|---|
| Cash flow from operating activities | (29.1) |
| Net cash from / (used in) operating activities | (29.1) |
| Cash flow from investing activities | (25.0) |
| Net cash from / (used in) investing activities | (25.0) |
| Cash flow from financing activities | 56.9 |
| Net cash from / (used) in financing activities | 56.9 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 2.8 |
| Net increase / (decrease) in cash and cash equivalents | 2.8 |
| Cash and cash equivalents at the beginning of the year | 8.6 |
| Cash and cash equivalents at the end of the year | 11.4 |
| Detailed Income Statement | FY 19-20 (in Cr) |
|---|---|
| 42.0 | |
| 77.3 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (35.3) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (35.3) |
| Extraordinary items before tax | 0 |
| Total profit before tax | (35.3) |
| 0 | |
| Total profit (loss) for period from continuing operations | (35.3) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | (35.3) |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 19-20 (in Cr) |
|---|---|
| 47.8 | |
| 47.8 |
| Detailed Cash Flow Statement | FY 19-20 (in Cr) |
|---|
| Detailed Income Statement | FY 18-19 (in Cr) |
|---|---|
| 33.3 | |
| 60.3 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (27.0) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (27.0) |
| Extraordinary items before tax | 0 |
| Total profit before tax | (27.0) |
| 0 | |
| Total profit (loss) for period from continuing operations | (27.0) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | (27.0) |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 18-19 (in Cr) |
|---|---|
| 17.8 | |
| 17.8 |
| Detailed Cash Flow Statement | FY 18-19 (in Cr) |
|---|
| Detailed Income Statement | FY 17-18 (in Cr) |
|---|---|
| 18.5 | |
| 35.3 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (16.7) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (16.7) |
| Extraordinary items before tax | 0 |
| Total profit before tax | (16.7) |
| (0.0) | |
| Total profit (loss) for period from continuing operations | (16.7) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | (16.7) |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 17-18 (in Cr) |
|---|---|
| 7.5 | |
| 7.5 |
| Detailed Cash Flow Statement | FY 17-18 (in Cr) |
|---|
| Detailed Income Statement | FY 16-17 (in Cr) |
|---|---|
| 7.5 | |
| 20.4 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (12.9) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (12.9) |
| Extraordinary items before tax | 0 |
| Total profit before tax | (12.9) |
| 0.0 | |
| Total profit (loss) for period from continuing operations | (12.9) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | (12.9) |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 16-17 (in Cr) |
|---|---|
| 4.8 | |
| 4.8 |
| Detailed Cash Flow Statement | FY 16-17 (in Cr) |
|---|
| Detailed Income Statement | FY 15-16 (in Cr) |
|---|---|
| 1.2 | |
| 0 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | 1.2 |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | 1.2 |
| Extraordinary items before tax | 0 |
| Total profit before tax | 1.2 |
| 0 | |
| Total profit (loss) for period from continuing operations | 1.2 |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | 1.2 |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 15-16 (in Cr) |
|---|---|
| 4.9 | |
| 4.9 |
| Detailed Cash Flow Statement | FY 15-16 (in Cr) |
|---|
| Detailed Income Statement | FY 14-15 (in Cr) |
|---|---|
| 0.0 | |
| 0.3 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (0.3) |
| Exceptional items before tax | 0 |
| Total profit before extraordinary items and tax | (0.3) |
| Extraordinary items before tax | 0 |
| Total profit before tax | (0.3) |
| 0 | |
| Total profit (loss) for period from continuing operations | (0.3) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | 0 |
| Total profit (loss) for period | (0.3) |
| Basic earning per equity share before extraordinary items | (0.0) |
| Diluted earnings per equity share before extraordinary items | (0.0) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 14-15 (in Cr) |
|---|---|
| 0.2 | |
| 0.2 |
| Detailed Cash Flow Statement | FY 14-15 (in Cr) |
|---|
| Detailed Income Statement | FY 13-14 (in Cr) |
|---|---|
| 0 | |
| 0.0 | |
| Profit/(Loss) before tax | (0.0) |
| 0 | |
| Profit/(Loss) for the year | (0.0) |
| Detailed Balance Sheet | FY 13-14 (in Cr) |
|---|---|
| 0.0 | |
| 0.0 |
| Detailed Cash Flow Statement | FY 13-14 (in Cr) |
|---|---|
| Cash flow from operating activities | 0 |
| Net cash from/(used in) operating activities | 0 |
| Cash flow from investing activities | 0 |
| Net cash from/(used in) investing activities | 0 |
| Cash flow from financing activities | 0 |
| Net cash from/(used) in financing activities | 0 |
| Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes | 0 |
| Effect of exchange rate changes on cash and cash equivalents | 0 |
| Net increase /(decrease) in cash and cash equivalents | 0 |
| Cash and cash equivalents at the beginning of the year | 0 |
| Cash and cash equivalents at the end of the year | 0 |
As of Mar 30, 2026 • Healthians
| Shareholder | Category | Shares (Mn) | % Holding |
|---|---|---|---|
| WestBridge AIF - I | Fund | 0.28M | 24.26% |
| Renu Sahni | Other People | 0.13M | 11.36% |
| DG Resona Ventures No. 1 Investment Limited | Fund | 0.09M | 7.54% |
| Deepak Sahni | Founder | 0.08M | 6.95% |
| Beenext Accelerate Fund | Fund | 0.07M | 5.83% |